-
Signature
-
/s/ Chandra Adams, as Attorney-in-Fact
-
Issuer symbol
-
CLYM
-
Transactions as of
-
07 Aug 2025
-
Net transactions value
-
$0
-
Form type
-
4
-
Filing time
-
11 Aug 2025, 16:15:08 UTC
Quoteable Key Fact
"Stephen Basil Thomas filed Form 4 for Climb Bio, Inc. (CLYM) on 11 Aug 2025."
Quick Takeaways
- This page summarizes Stephen Basil Thomas's Form 4 filing for Climb Bio, Inc. (CLYM).
- 1 reported transaction and 0 derivative rows are listed below.
- Filing timestamp: 11 Aug 2025, 16:15.
What Changed
- Previous filing in this sequence was filed on 01 Jul 2025.
- Current net transaction value: $0.
Why This Matters
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Reporting Owners (1)
| Name |
Relationship |
Address |
Signature |
Signature date |
CIK |
| Thomas Stephen Basil |
Director |
C/O CLIMB BIO, INC., 20 WILLIAM STREET, SUITE 145, WELLESLEY HILLS |
/s/ Chandra Adams, as Attorney-in-Fact |
11 Aug 2025 |
0002027962 |
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
CLYM |
Common Stock |
Award |
$0 |
+100,375 |
+49% |
$0.000000 |
304,657 |
07 Aug 2025 |
Direct |
F1 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Explanation of Responses: